Rebranding as Hilo, the Swiss company will scale its “blood pressure intelligence” to the US this year, following expected FDA approval.
Via Lionel Reichardt / le Pharmageek
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
![]() ![]()
Richard Platt's curator insight,
June 3, 1:46 PM
In recent years, the landscape of Parkinson’s disease management has been dramatically transformed by the advent of wearable technology.A groundbreaking systematic review, led by Packer, Debelle, Bailey, and colleagues, published in npj Parkinson’s Disease, illuminates how these devices are revolutionizing...
|
|
Rebranding as Hilo, the Swiss company will scale its “blood pressure intelligence” to the US this year, following expected FDA approval.